Sleep Restriction and Obesity
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sleep restriction
Sponsored by

About this trial
This is an interventional basic science trial for Obesity
Eligibility Criteria
Inclusion Criteria:
- Age 18-40 years
- BMI of 18.5-30 kg/m2
- Not a current smoker or tobacco user
- No chronic medical or psychiatric disorders
- On no prescription medications other than second generation antihistamines (cetirizine, fexofenadine, desloratadine, loratadine, etc), oral contraceptive pills, or intrauterine devices
- History of normal sleep patterns, defined as nocturnal sleep duration of 6.5-8 hours per night without regular daytime naps
Exclusion Criteria:
- The investigators will exclude subjects who have any medical or psychiatric disorders
- History of anxiety or depression
- Those taking any medications other than non-sedating antihistamines or oral contraceptives will be excluded
- Those found to have depression on a depression screening tool (BDI-II) will be excluded
- Current smokers will be excluded
- All female subjects will undergoing a screening pregnancy test and excluded if positive
- Subjects found to have significant sleep disorders will be excluded
Sites / Locations
- Mayo Clinic in Rochester
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Sleep restriction
Normal sleep
Arm Description
Sleep restriction
Normal sleep
Outcomes
Primary Outcome Measures
Change in caloric intake and hunger
Change in caloric intake and hunger, measured during acclimation, experimental and recovery timepoints.
Change in energy expenditure
Change in energy expenditure, including activity energy expenditure, thermic effect of food (TEF), and basal metabolic rate (BMR), measured during acclimation, experimental and recovery timepoints..
Change in fat tissue characteristics and body composition
Changes in fat tissue characteristics from serial fat biopsies, and in body composition from DEXA and CT imaging, measured during acclimation, experimental and recovery timepoints.
Change in metabolic hormones
Change in metabolic hormones measured during acclimation, experimental and recovery timepoints.
Secondary Outcome Measures
Change in neurocognitive deficits
Change in neurocognitive function measured by battery, measured during acclimation, experimental and recovery timepoints..
Change in blood pressure and autonomic function
Change in mean arterial blood pressure and autonomic function, measured during acclimation, experimental and recovery timepoints.
Change in markers of inflammation and endothelial function
Change in markers of inflammation and endothelial function, measured during acclimation, experimental and recovery timepoints.
Change in electrocardiographic characteristics
Change in electrocardiographic characteristics, measured during acclimation, experimental and recovery timepoints.
Change in arterial stiffness
Change in arterial stiffness, measured during acclimation, experimental, and recovery timepoints.
Change in cardiovascular reactivity
Change in cardiovascular reactivity, measured during acclimation, experimental, and recovery timepoints.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01580761
Brief Title
Sleep Restriction and Obesity
Official Title
Sleep Restriction and Obesity
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
July 2012 (undefined)
Primary Completion Date
May 1, 2018 (Actual)
Study Completion Date
May 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Insufficient sleep may be one of the most common, and most preventable, obesity risk factors. The investigators wish to determine whether 14 nights of modest sleep restriction results in increased energy balance, thus potentially increasing the risk of obesity. The investigators hypothesize that sleep restriction will result in increased energy balance.
Detailed Description
Numerous studies have reported that self-reported short sleep duration is associated with obesity and weight gain. Insufficient sleep may be one of the most common, and most preventable, obesity risk factors. Given that sleep restriction is largely voluntary and potentially correctable, understanding the mechanisms that link insufficient sleep to positive energy balance and the development of obesity, particularly visceral obesity, is crucial to clinical applications, public health policy, and informing future studies. The investigators wish to determine whether 14 nights of modest sleep restriction results in increased energy balance, thus potentially increasing the risk of obesity. The investigators will combine energy balance, biomarker, and imaging data with state-of-the art sleep monitoring to provide unambiguous data on the effects of sleep restriction on obesity. Together, the investigators findings will help explain whether the reduced sleep duration in the general population may be contributing to the current epidemic of obesity, and suggest strategies to reduce this risk.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
13 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sleep restriction
Arm Type
Experimental
Arm Description
Sleep restriction
Arm Title
Normal sleep
Arm Type
No Intervention
Arm Description
Normal sleep
Intervention Type
Behavioral
Intervention Name(s)
Sleep restriction
Intervention Description
14 days of sleep restriction, 4 hours of sleep per day.
Primary Outcome Measure Information:
Title
Change in caloric intake and hunger
Description
Change in caloric intake and hunger, measured during acclimation, experimental and recovery timepoints.
Time Frame
baseline to 21 days
Title
Change in energy expenditure
Description
Change in energy expenditure, including activity energy expenditure, thermic effect of food (TEF), and basal metabolic rate (BMR), measured during acclimation, experimental and recovery timepoints..
Time Frame
baseline to 21 days
Title
Change in fat tissue characteristics and body composition
Description
Changes in fat tissue characteristics from serial fat biopsies, and in body composition from DEXA and CT imaging, measured during acclimation, experimental and recovery timepoints.
Time Frame
baseline to 21 days
Title
Change in metabolic hormones
Description
Change in metabolic hormones measured during acclimation, experimental and recovery timepoints.
Time Frame
baseline to 21 days
Secondary Outcome Measure Information:
Title
Change in neurocognitive deficits
Description
Change in neurocognitive function measured by battery, measured during acclimation, experimental and recovery timepoints..
Time Frame
baseline to 21 days
Title
Change in blood pressure and autonomic function
Description
Change in mean arterial blood pressure and autonomic function, measured during acclimation, experimental and recovery timepoints.
Time Frame
baseline to 21 days
Title
Change in markers of inflammation and endothelial function
Description
Change in markers of inflammation and endothelial function, measured during acclimation, experimental and recovery timepoints.
Time Frame
baseline to 21 days
Title
Change in electrocardiographic characteristics
Description
Change in electrocardiographic characteristics, measured during acclimation, experimental and recovery timepoints.
Time Frame
baseline to 21 days
Title
Change in arterial stiffness
Description
Change in arterial stiffness, measured during acclimation, experimental, and recovery timepoints.
Time Frame
baseline to 21 days
Title
Change in cardiovascular reactivity
Description
Change in cardiovascular reactivity, measured during acclimation, experimental, and recovery timepoints.
Time Frame
baseline to 21 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age 18-40 years
BMI of 18.5-30 kg/m2
Not a current smoker or tobacco user
No chronic medical or psychiatric disorders
On no prescription medications other than second generation antihistamines (cetirizine, fexofenadine, desloratadine, loratadine, etc), oral contraceptive pills, or intrauterine devices
History of normal sleep patterns, defined as nocturnal sleep duration of 6.5-8 hours per night without regular daytime naps
Exclusion Criteria:
The investigators will exclude subjects who have any medical or psychiatric disorders
History of anxiety or depression
Those taking any medications other than non-sedating antihistamines or oral contraceptives will be excluded
Those found to have depression on a depression screening tool (BDI-II) will be excluded
Current smokers will be excluded
All female subjects will undergoing a screening pregnancy test and excluded if positive
Subjects found to have significant sleep disorders will be excluded
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Virend Somers, MD, PhD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic in Rochester
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
35361348
Citation
Covassin N, Singh P, McCrady-Spitzer SK, St Louis EK, Calvin AD, Levine JA, Somers VK. Effects of Experimental Sleep Restriction on Energy Intake, Energy Expenditure, and Visceral Obesity. J Am Coll Cardiol. 2022 Apr 5;79(13):1254-1265. doi: 10.1016/j.jacc.2022.01.038.
Results Reference
derived
Links:
URL
https://www.mayo.edu/research/clinical-trials
Description
Mayo Clinic Clinical Trials
Learn more about this trial
Sleep Restriction and Obesity
We'll reach out to this number within 24 hrs